Pfizer Indonesia Calls Biotechnology Studies Less Interesting, Here's The Reason

Research illustration. (ThisisEngineering RAEng /Unsplash)

JAKARTA - Pfizer Indonesia revealed the main challenges that must be faced by Indonesia, especially in the field of health biotechnology today. This challenge must be answered to advance the field of biotechnology in Indonesia

"The field of biotechnology studies from the data we obtained from an independent study institution, it seems that the field of health biotechnology is not very attractive to high school or high school graduates in Indonesia," said Pfizer Indonesia's Director of Policy and Public Relations Bambang Chriswanto in a media briefing 'Launching of Pfizer Biotech' Fellowship' online, citing Antara Wednesday 11 August.

He revealed, the students still have thoughts by studying the field of biotechnology, they do not have the potential and do not attract their interest.

Bambang suggested, every related party to promote socialization related to the health biotechnology study program to students who will enter college.

"We believe that with the socialization, role and transformation of universities that are supported by industry, and in the context of the current pandemic, we hope to provide new fresh momentum for prospective students to participate in this field of study at public or private universities," he explained, providing a way to complete this. the problem.

Meanwhile, Chairman of the Indonesian Biotechnology Study Program Association (IPSBI) Dr. ret. grout. Sulistyo Emantoko said that the next challenge that must be faced is that biotechnology students need to know more about the real problems that occur in the field.

"There has been a lot of research. One thing, that's why I really support how researchers or people who are engaged in this course can depend on industrial problems that have real problems about what happens in the field connected to health biotechnology," said Sulistyo.

He said the level of knowledge of biotechnology in Indonesia is currently very broad. However, what is needed is to know the real problems that are happening in the industry, so that each party can develop their thoughts and collaborate more deeply with the industry.

Responding to this problem, he suggested that students who are in the biotechnology study program extend the internship period so that they can experience all activities in this field.

"Let's say they can do industrial internships, usually one to two months, can be extended to six months, doing all the work in this kind of industry. It is hoped that they will know the real problems of health technology in the industry," he concluded.